Filing Flows

Filing Flows › Companies › Albemarle › Cash flow

Albemarle cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$325M in Q3 2026 · $1.4B over twelve months

Operating cash flow$406M
Capital spending−$80.4M
Free cash flow+$325M
Cash / net income1.3×

Analysis

In Q3 2026, Albemarle generated $406M of operating cash flow and spent $80.4M on capital projects, leaving free cash flow of $325M. That is $102M more than in Q3 2025 ($223M).

Over the twelve months to Sep 30, 2026, operating cash flow was $1.9B; the largest uses were net borrowing (+) / repaid (−) ($1.7B), capital spending ($406M), dividends ($191M); besides operations, cash came from other investing ($597M), shares issued ($21.4M); the cash balance fell by $85.8M.

Operating cash flow was $406M against net income of $317M — 1.3× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$168M, other non-cash −$33.1M, deferred taxes −$10.2M.

Free cash flow

Albemarle: free cash flow by quarterAlbemarle: free cash flow by quarter−$347MQ4 2024$365MQ1 2025−$129MQ2 2025$223MQ3 2025$233MQ4 2025$248MQ1 2026$638MQ2 2026$325MQ3 2026
Operating cash flow less capital spending.
Albemarle: operating cash flow against capital spendingAlbemarle: operating cash flow against capital spendingOperating cash flowCapital spending−$4.4M$343MQ4 2024$547M$183MQ1 2025−$9.0M$120MQ2 2025$356M$132MQ3 2025$388M$155MQ4 2025$346M$98.7MQ1 2026$710M$71.7MQ2 2026$406M$80.4MQ3 2026
Latest (Q3 2026): Operating cash flow $406M, Capital spending $80.4M.

Capital allocation, year by year

Albemarle: where the cash came from (up) and went (down), by fiscal yearAlbemarle: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingDividendsFY2021: Operating cash flow $344MFY2021: Net borrowing −$1.1BFY2021: Shares issued $1.5BFY2021: Asset sales $290MFY2021: Capital spending −$954MFY2021: Dividends −$178M$2.1BFY2021FY2022: Operating cash flow $1.9BFY2022: Net borrowing $866MFY2022: Shares issued $2.8MFY2022: Capital spending −$1.3BFY2022: Dividends −$184M$2.8BFY2022FY2023: Operating cash flow $1.3BFY2023: Net borrowing $944MFY2023: Shares issued $190KFY2023: Capital spending −$2.2BFY2023: Dividends −$187M$2.3BFY2023FY2024: Operating cash flow $688MFY2024: Net borrowing −$1.3BFY2024: Shares issued $2.2BFY2024: Asset sales $29.1MFY2024: Capital spending −$1.7BFY2024: Dividends −$189M$3.0BFY2024FY2025: Operating cash flow $1.3BFY2025: Net borrowing −$460MFY2025: Shares issued $3.2MFY2025: Asset sales $32.8MFY2025: Capital spending −$590MFY2025: Dividends −$191M$1.3BFY2025
Over these 5 years operating cash flow totalled $5.6B; the largest uses were capital spending ($6.6B) and net borrowing ($2.8B). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.8B
Debt$1.9B
Net debt$35.4M
Due within a year$74.1M

Albemarle funds itself: free cash flow was $1.4B over the last twelve months, and $1.8B of cash and investments stands against $1.9B of debt ($74.1M due within a year, 24.9× covered by cash).

Albemarle: debt maturities by year (FY2025)Albemarle: debt maturities by year (FY2025)$74.1MYear 1$710MYear 2$649MYear 3$232MYear 4$60.0MYear 5$1.5BAfter year 5
Principal due in each year as disclosed in the annual report, against $1.8B of cash and investments now.

Where the cash came from and went

Albemarle: sources (+) and uses (−) of cash, Q3 2026Albemarle: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$406MCash drawn (+) / kept (−)−$214MCapital spending−$80.4MDividends−$47.8MOther financing−$40.6MPartners−$18.6MOther investing−$5.2MExchange rates$3.5MNet borrowing (+) / repaid (−)−$2.2MTaxes on employees’ shares−$302K
Albemarle: sources (+) and uses (−) of cash, TTM to Q3 2026Albemarle: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$1.9BNet borrowing (+) / repaid (−)−$1.7BOther investing$597MCapital spending−$406MDividends−$191MOther financing−$164MCash drawn (+) / kept (−)$85.8MPartners−$56.1MShares issued$21.4MTaxes on employees’ shares−$8.6MAsset & business sales$7.2MExchange rates$1.3M

From profit to cash

Albemarle: net income to operating cash flow, Q3 2026Albemarle: net income to operating cash flow, Q3 2026Net income$317MDepreciation & amortization$168MStock-based pay$9.6MDeferred taxes−$10.2MOther non-cash−$33.1MOperating cash flow$406M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$406M−$80.4M−$47.8M−$2.2M—−$214M$325M
Q2 2026$710M−$71.7M−$47.7M−$2.1M$10.7M−$542M$638M
Q1 2026$346M−$98.7M−$47.7M−$1.3B$8.9M$528M$248M
Q4 2025$388M−$155M−$47.6M−$443M$1.7M$314M$233M
Q3 2025$356M−$132M−$47.7M−$2.5M$308K−$125M$223M
Q2 2025−$9.0M−$120M−$47.6M−$2.5M—−$288M−$129M
Q1 2025$547M−$183M−$47.6M−$12.0M$1.2M−$326M$365M
Q4 2024−$4.4M−$343M−$47.6M−$3.6M$260K$472M−$347M

Albemarle: income statement and cash flow

Albemarle, Q3 2026: revenue $1.6B (+19% year over year), operating margin 9.5%. The chart follows the revenue to costs, profit and cash.

Albemarle: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.